TEMPLATE DESIGN © 2008 www.PosterPresentations.com Outcome of Large Loop Excision of Transformation Zone (LLETZ ) in women over forty at two London Hospitals.

Slides:



Advertisements
Similar presentations
MANAGEMENT OF THE ABNORMAL PAP SMEAR
Advertisements

Cervical Cancer. Dr. Swapna Chaudhary M.S. (MUM) Consultant Obstetrician & Gynaecologist Infertility Specialist.
Treatment Options for CIN Cervical Cancer screening is designed to detect CIN If CIN is present treatment should theoretically avoid subsequent cancer.
Sample Taker Training Cervical Cytology & Management of Abnormalities.
Comparison of HPV Testing and Spectroscopy Combined with Cytology for the Detection of High- grade Cervical Neoplasia C Werner, W Griffith III, R Ashfaq,D.
STI testing in Europe, accessibility and availability I. Sziller 1 st Dept. Obstetrics and Gynecology, Semmelweis University Medical School.
M. Munjoma. Outline Burden of HPV Disease HPV in Zimbabwe HPV Lab Development HPV Protocols.
Cervical Cancer Cervical dysplasia Cervical cancer Causes Risk factors
Benign Conditions Of The Cervix Dr. Abdalla H. Elsadig MD.
HPV and cervical screening Test of cure
Screening for Cervical Cancer
HUMAN PAPILLOMA VIRUS and CERVICAL CARCINOMA Roger J Rand.
Benign and premalignant disease of the cervix
Cervical Cancer: Prevention and Treatment
Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening Obstetrics and Gynecology, Volume 103,
Case Presentations: Pre-Invasive Cervical Neoplasia
COLPOSCOPY Cervical Screening QARC Training School October 2012.
November 2005 Guy Hayhurst Consultant in Public Health, Eastern Cheshire PCT OVERVIEW OF THE CERVICAL SCREENING PROGRAMME.
AN AUDIT OF PAP SMEAR, COLPOSCOPY AND HISTOLOGY RESULTS FROM IN TUNGARU CENTRAL HOSPITAL (KIRIBATI)
Meta-analysis of trials of radiotherapy in DCIS Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)
Cervical Cancer Screening
 The term post menopause is applied to women who have not experienced a menstrual bleed for a minimum of 12 months, assuming that they do still have.
CANCER CERVIX A PREVENTABLE CANCER Dr NEETA DHABHAI Sr Consultant. – Gynaecologist Member Expert - Indian Cancer Winners’ Association
Cervical Sample Taker Training 2015 THE NHS CERVICAL SCREENING PROGRAMME (NHSCSP)
Screening for Cervical Cancer Max Brinsmead MB BS PhD May 2015.
Abnormal Pap in Pregnancy Alexander Burnett, MD Division Gyn Oncology, UAMS April, 2006.
Screening for cervical cancer. Screening for cervical lesions Common disease Cancer is preventable Screening is easy MUST BE PERFORMED.
In the Name of God. Screening of Cervical Cancer Pap smear and colposcopy F.Behnamfar Gynecology Oncology Fellowship Associate Professor Isfahan University.
Cervical Intraepithelial Neoplasm
The up-to-date evidence on colposcopy practice
TEMPLATE DESIGN © Evaluation of the antenatal care and obstetric outcome of obese pregnant women and those with a healthy.
Adult Medical-Surgical Nursing
Colposcopy & Research.  Arch Gynecol Obstet May 26. [Epub ahead of print] Arch Gynecol Obstet.  Risk factors for treatment failure following cold.
Obstetric outcome following cervical treatment for CIN By M Lokman, M DeLange.
TEMPLATE DESIGN © Maternal Obesity & Obstetric outcomes John R, Johnson JK, Pavey J Department of Obstetrics and Gynaecology,
Sheffield Gynaecological Cancer CentreSheffield Teaching Hospitals PRIMARY HPV SCREENING A view from colposcopy John Tidy Consultant Gynaecological Oncologist.
TEMPLATE DESIGN © Negative LLETZ following severe dyskaryosis: a curious phenomenon Üçyiğit A, Jones M H, Dutta A, El.
Premalignant lesions of the cervix. Applied anatomy.
Screening of genital cancers Evidence Based Presented by Dr\ Heba Nour.
CERVICAL SCREENING ANGELIKA KAUFMANN, ST4, UHCW, MEDICAL STUDENT INDUCTION, 2015.
TEMPLATE DESIGN © Laparoscopic assisted vaginal hysterectomy in a District General Hospital- Audit of clinical practice.
Appendix 2 Comparison of screening from age 20 and age 25 Table of harms and benefits.
2006 ASCCP Consensus Guidelines Anne L. Kittendorf, MD FAAFP Assistant Professor University of Michigan Department of Family Medicine.
HPV and Pap Guidelines Jennifer Johnson MD. Objectives 1. Define the new PAP guidelines. 2. Identify the historical trends and new evidence resulting.
HPV-related anogenital cancers
Cervical Cancer: Experiences from a Cohort of HIV-infected Women Pascoe M, Magure T, Mudhokwani P et al Abstract: MOAB0202.
Date of download: 6/26/2016 From: Cost-Effectiveness of Human Papillomavirus Vaccination and Cervical Cancer Screening in Women Older Than 30 Years in.
Cervical cancer screening and treatment among HIV+ women in Cambodia: feasible and high yielding M.-E. Raguenaud 1, P. Isaakidis 1, S.A. Khim 1, C. Ping.
Understanding Test Results
Public Health England leads the NHS Screening Programmes
Performance of mRNA- and DNA-based high-risk human papillomavirus assays in detection of high-grade cervical lesions ELINA VIRTANEN1, ILKKA KALLIALA2,3,
Trreatment of Preinvasive Lesions
Cytology Codes & management Colposcopy- Management of cervical lesions
Cervical Cancer Colposcopy & Treatment
Efficacy of random cervical biopsy and routine endocervical curettage in subjects with normal colposcopy.
Risk factors for cervical intraepithelial neoplasia recurrence after loop electrosurgical excision procedure in HIV-1-infected and non-infected women.
Dr N Shailaja Dr Pradeep
An Audit of Colposcopy Practice on Mild Dyskaryosis or Borderline Changes on Cervical Smear and the Effectiveness of “See & Treat” vs. Biopsy and Recall.
Colposcopy triage. Satisfactory colposcopy is defined as complete visualization of the squamocolumnar epithelium, which comprises the cervical region most.
HPV DNA SCREENING, FROM CO-TESTING
Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade.
QUIZ QUESTIONS 1) WHAT ARE THE TWO TYPES OF CERVICAL CANCER?
SBÜ KAYSERİ ERH Doç. Dr. Gökhan Açmaz
Public Health England leads the NHS Screening Programmes
Screening to Prevent Invasive Cervical Cancer (Resource-Stratified)
Cervical excisional treatment of young women: A population-based study
SH-sheikhhasani Gyn-oncologist
HUMAN PAPILLOMA VIRUS and CERVICAL CARCINOMA
Presentation transcript:

TEMPLATE DESIGN © Outcome of Large Loop Excision of Transformation Zone (LLETZ ) in women over forty at two London Hospitals Outcome of Large Loop Excision of Transformation Zone (LLETZ ) in women over forty at two London Hospitals Collaborative audit between King’s College Hospital and Imperial St Mary’s Hospital. Collaborative audit between King’s College Hospital and Imperial St Mary’s Hospital. M Aziz,N Marcus,D Lyons M Aziz,N Marcus,D Lyons Objectives The prevalence of CIN 3 and invasive cancer in women over the age of 50 is low: 11 in 100,000 in well screened women Versus… 59 in 100,000 women in the population as a whole(1). Large Loop Excision of Transformation Zone (LLETZ) is widely used procedure to treat Cervical Intraepithelial Neoplasia (CIN) Advantages: Carried out in the out-patient clinic, simple Local anaesthesia Histological examination of the entire Transformation Zone (TZ). Risks of LLETZ Haemorrhage Infection Discharge and bleeding Pain Changes in menstrual cycle Psychological impact …. AND concerns of long-term pregnancy- related morbidity associated with excision in women of reproductive age group While there are some concerns in treating young age group because of the risk of preterm labour, this is less of a concern in women over the age of forty, thus it is likely that we would treat low grade disease in women after the age of forty. Retrospective study to review of LLETZ treatment in women over the Age of forty between two London hospitals - St Mary’s Hospital (SMH) and King’s College Hospital (KCH) five year period Audit proforma designed, anonymised data collected. Manually transposed onto Excel spreadsheet Data Analysis – each Unit. Analysis especially with regards to outcomes of LLETZ Analysis of over 40’s and under 40’s Comparison of results/outcomes in each Unit A total number of 2036 patients underwent excisional cervical treatment over five years between There was 687 patients from KCH and 1376 patients from SMH. Of those there were 575(28%)patients over the age the age of forty. Patients characteristics Conclusions References There is higher incidence of high grade lesions in under 40 group of both hospitals. The incidence of CGIN was similar in both groups There was slightly higher rate of microinvasive cancer at SMH over 40 group. Older women had more LLETZ treatment and for less severe disease compared to younger women(<40). The difference thresholds for performing LLETZ in the two groups may be attributed to concerns over the risk of preterm labour in younger women. OPTIONAL LOGO HERE LESS THAN 40 MORE THAN 40 NO CIN/ HPV32* (6.9%)73* (32%) HIGH GRADE363(79%)105 (47%) LOW GRADE58 (12.6%) 44(20%) INVASIVE2 (0.4%)1 (0.4%) CGIN7 (1.5%)2 (0.9%) Referral cytology/ reason LESS THAN 40 MORE THAN 40 NO CIN29* (2.7%)14 * (5%) HPV102 ( 9.5%)99(29%) CIN1228 (21.3%)69(20.5%) CIN2284 (26.5%)75(22.5%) CIN3400 (37.5%)60(17%) CGIN17 (1.5%)5 (1.5%) MICRO/INVASIVE10(1%)12 (3.5%) OTHER CANCERS 3(1%) * Most of those patients LLETZ was done for clinical indications/PCB/Polyps. Negative LETZ reviewed at MDT LESS THAN 40 MORE THAN 40 NO CIN/ HPV32* (6.9%)73* (32%) HIGH GRADE363(79%)105 (47%) LOW GRADE58 (12.6%) 44(20%) INVASIVE2 (0.4%)1 (0.4%) CGIN7 (1.5%)2 (0.9%) Treatment histology outcome KCH Treatment histology outcome SMH There is higher incidence of high grade lesions in under 40 group of both hospitals. The incidence of CGIN was similar in both groups There was slightly higher rate of microinvasive cancer at SMH over 40 group. Results 1.NHSCSP Publication No 20 May 2010 ResultsMethods